Frontiers in Oncology

Correction

Published on 23 Apr 2025

Corrigendum: Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC

in Molecular and Cellular Oncology

Julia Meidenbauer
Matthias Wachter
Sebastian R. Schulz
Nada Mostafa
Lilli Zülch
Benjamin Frey
Rainer Fietkau
Udo S. Gaipl
Tina Jost

Frontiers in Oncology

doi 10.3389/fonc.2025.1607882

198 views

Case Report

Accepted on 22 Apr 2025

Rare comorbidity of colon cancer, hepatic malignant mesothelioma, and abdominal Ewing's sarcoma:A case report

in Surgical Oncology

Yanru Li
Lukang Teng
Shupeng Wang
Xudong Wu
Tianchen Huang

Frontiers in Oncology

doi 10.3389/fonc.2025.1558347

170 views

Original Research

Accepted on 22 Apr 2025

Real-world treatment patterns and outcomes among patients initiating SEQuential Regorafenib and Trifluridine/Tipiracil+/-bevacizumab in patients with metastatic colorectal cancer in a US community setting (SEQRT2)

in Gastrointestinal Cancers: Colorectal Cancer

Tanios Bekaii-Saab
Ila Sruti
Junxin Shi
Wei Dai
Gregory Patton
Sreevalsa Appukkuttan
Brian Hocum
Arvind Katta
Svetlana Babajanyan
David Cosgrove

Frontiers in Oncology

doi 10.3389/fonc.2025.1591245

227 views

Case Report

Accepted on 22 Apr 2025

Cord blood therapy for pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: case series and review

in Hematologic Malignancies

Zhen Li
Sujing Zhuang
Gui Ruirui
Binglei Zhang
Wenli Zhang
Juan Wang
Yingling Zu
Fei Yang
Xiangke Xin
Yanyan Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1585088

139 views

Original Research

Accepted on 22 Apr 2025

Efficacy and safety of blinatumomab in Chinese patients with relapsed/refractory B-cell acute lymphoblastic leukemia: a single-center retrospective study

in Hematologic Malignancies

Yan Wang
Chun Chang
Zhen Wang
Jie Zhao
Jingbo Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1587185

123 views

Original Research

Accepted on 22 Apr 2025

Efficacy and Safety of Pegylated Interferon in the Treatment of JAK2 V617F -Positive Polycythemia Vera with a Dose De-escalation Strategy: A Single-Center Retrospective Study

in Hematologic Malignancies

Long Chang
Wen-Xin Li
Hao Cai
Jian Li
Minghui Duan

Frontiers in Oncology

doi 10.3389/fonc.2025.1586839

128 views

Case Report

Accepted on 22 Apr 2025

Hyperleukocytosis, Leukemoid Reaction Caused by Malignant Peritoneal Mesothelioma: A Case Report and Review of Literature

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Kaibo Zhu
Dan Zhou
Kang Liu
Lingzhen Wu
Juan Jin
Zimian Luo

Frontiers in Oncology

doi 10.3389/fonc.2025.1550868

Original Research

Accepted on 22 Apr 2025

The value of spectral CT quantitative parameters in predicting Ki-67 level in ovarian cancer

in Cancer Imaging and Image-directed Interventions

Siwen Pang
Meng Wu
Haijia Yu
Tiantian Ma
Jianhua Liu
Siwen Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1576690

Original Research

Accepted on 22 Apr 2025

Adeno-associated virus vector modification based on directed evolution technology for gene therapy targeting head and neck squamous cell carcinoma

in Head and Neck Cancer

Yiyuan Zhu
Wei Ji
Qi Zhang
Yanbo Dong
Liangfa Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1566584

133 views

Original Research

Accepted on 22 Apr 2025

Predicting Day-One Mobility in Partial Nephrectomy Patients Using Preoperative and Intraoperative Clinical Parameters

in Cancer Imaging and Image-directed Interventions

Meijuan Xu
Qiuxuan Zhang
Xiaohui Mo
Yanmei Liu
Man Peng
Xuexia Ma

Frontiers in Oncology

doi 10.3389/fonc.2025.1528834

Original Research

Accepted on 22 Apr 2025

Preclinical NCI-MPACT: Prospective Modeling of the Mutation-Based NCI-MPACT Clinical Trial Therapeutic Strategy in Patient-Derived Xenograft Models

in Cancer Molecular Targets and Therapeutics

Yvonne A. Evrard
Sergio Ynocensio Alcoser
Michael Mullendore
Li Chen
Chih-Jian Lih
Vishnuprabha Rahul Kannan
Vivekananda Datta
Lindsay Dutko
Shahanawaz Jiwani
Larry Rubinstein

Frontiers in Oncology

doi 10.3389/fonc.2025.1571635

123 views

Systematic Review

Accepted on 22 Apr 2025

Endoscopic surgery Versus Various Open Approaches in Esthesioneuroblastoma: A systematic Review of the Literature

in Head and Neck Cancer

Michael Koch
Matthias Balk
Sven-Martin Schlaffer
Moritz Allner
Heinrich Iro
Sarina Mueller

Frontiers in Oncology

doi 10.3389/fonc.2025.1512771

Systematic Review

Accepted on 22 Apr 2025

The evolution of FLASH radiotherapy: a bibliometric analysis

in Radiation Oncology

Shuokai Jia
Weige Wei
Yiwen He
Haichuan Yan
Siru Zou
Qing Xiao
Guangjun Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1580848

165 views

Original Research

Accepted on 22 Apr 2025

Effect of physical parameter differences on the performance of a knowledgebased partial arc VMAT RapidPlan model for left breast cancer

in Radiation Oncology

Hai-Liang Guo
Zeng-Hong Lu
Jing-Hua Zhong
Huaiwen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1589270

Case Report

Accepted on 22 Apr 2025

Diagnosis and therapy of recurrent renal metastases after surgery for testicular seminoma: a rare case report and review of the literature

in Genitourinary Oncology

Zhuang Li
Yuanyuan Luo
Bo Yu
Hao Su
Dongbo Yuan
Jianguo Zhu

Frontiers in Oncology

doi 10.3389/fonc.2025.1542368

Review

Accepted on 22 Apr 2025

Recent status and trends regarding oxidative stress in gliomas (2013 -2025): a systematic review and bibliometric analysis

in Neuro-Oncology and Neurosurgical Oncology

Yijun Zeng
Xiaowen Lu
Yadan Wang
Jihong He
Lushun Zhang
Hui Cao
Li Cheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1586515

105 views